Abstract Purpose of Review Atrial fibrillation (AF) is a major risk factor for systemic embolism
and ischaemic stroke. Furthermore, AF-related strokes are associated with higher mortality …

Background Clinical complexity is common in atrial fibrillation (AF) patients. We assessed
the impact of clinical complexity on oral anticoagulant (OAC) treatment patterns and major …

Summary Background The 'Atrial fibrillation Better Care'(ABC) pathway has been proposed
to streamline a more holistic or integrated care approach to atrial fibrillation (AF) …

Thromboembolic events (TEE) associated with atrial fibrillation (AF) are highly recurrent and
usually severe, causing permanent disability or, even, death. Previous data consistently …

Background Previous studies suggested potential ethnic differences in the management and
outcomes of atrial fibrillation (AF). We aim to analyse oral anticoagulant (OAC) prescription …

Stroke prevention is crucial for the management of patients with atrial fibrillation (AF), and
several risk factors have been identified, which increase the risk of AF-related stroke. Among …

Background Clinical risk factors are common among patients with atrial fibrillation (AF), but
there are still limited data on their association with oral anticoagulant (OAC) treatment …

Background Clinical complexity, as the interaction between ageing, frailty, multimorbidity
and polypharmacy, is an increasing concern in patients with AF. There remains uncertainty …

Background Stroke prevention with oral anticoagulant (OAC) therapy, including non-vitamin
K antagonist oral anticoagulants (NOACs), is recommended in patients with atrial fibrillation …

Aims Chronic obstructive pulmonary disease (COPD) may influence management and
prognosis of atrial fibrillation (AF), but this relationship has been scarcely explored in …